Exascale Labs Holdings Inc. income statement

In fiscal 2026, Exascale Labs Holdings Inc. reported revenue of $14.8m, up 111.3% on the year before, operating income of −$4.8m (a -32.4% margin) and net income of −$12.2m, or −$8108.26 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Exascale Labs Holdings Inc.: income statement, annual
Fiscal year	2025Jun 2025	2026Jun 2026
Revenue	7	15
Cost of revenue	6	12
Gross profit	1	2
Research and development	3	5
Selling and marketing	1	0
General and administrative	0	1
Operating income	−3	−5
Income before tax	−8	−12
Net income	−8	−12
Diluted EPS	−$5106.44	−$8108.26
Diluted shares (average)	—	—
EBITDA	−3	−5

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

More: Application Software stocks compared, Technology sector, rankings of US companies

Figures from Exascale Labs Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Exascale Labs Holdings Inc.